Published Date : Aug 21, 2017
ALBANY, New York, August 21, 2017: Also known as non-insulin dependent diabetes, the Type 2 diabetes or adult-onset diabetes mellitus constitutes a majority of diabetes cases around the world. As per a study recently added to MarketResearchReports.biz, type 2 diabetes constitutes more than 90% of diabetes cases worldwide, while the remaining 5% to 10% of cases report type 1 diabetes. The report is titled “EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2026,” and is available for sale on the company website.
Various factors have stood responsible for exponential rise in the incidence of diabetes. Rising prevalence of obesity on account of physical inactivity, unhealthy dietary habits, and various other lifestyle factors pose modifiable risk of diabetes. However, there still remains a certain degree of possibility to curb or prevent them. On the flip side, non-modifiable risk factors such as family history, advancing age, and race/ethnicity can also put a person at risk of developing diabetes. Besides these, type 2 diabetes is often associated with comorbidities such as cardiovascular disease, dyslipidemia, and hypertension.
Against this backdrop, countries witnessing a high prevalence of obesity and cardiovascular ailments stand to offer more lucrative opportunities sellers of diabetes drugs. According to the report, between 2016 and 2026, the rate of diagnosed prevalent cases of type 2 diabetes is likely to rise at 3.88%. The US as per the report is likely to have the highest number of diagnosed type 2 diabetes prevalent cases, while Italy is expected to have the lowest number.
For Sample Copy, click here: https://www.marketresearchreports.biz/sample/sample/1287567
Information offered in the report is substantiated by longitudinal historical data, which in turn presents insights into the disease epidemiology across each market. The report also includes information obtained from in-depth research conducted across various countries. Besides this, data is sourced from peer-reviewed journals, national databases, and country-specific studies as well.
Information thus offered in the report is intended to help market players determine winning business strategies by understanding trends prevailing in the global type 2 diabetes market. Data provides in the report can also help quantifying patient population in the global market for type 2 diabetes. This information can be helpful in improving product design, launch plans, and pricing.
In addition to the aforementioned information, the report identifies trends prevalent in a few of the countries exhibiting the most lucrative opportunities such as China, India, Japan, the US, and EU. Information thus included in the report can help the pharmaceutical companies identify the most lucrative pockets within the global type 2 diabetes market. Using information published in the report to their favor, the market players can create winning strategies for the future. Considering the rate at which the prevalence of obesity and other lifestyle diseases is rising, the demand for effective treatment and therapeutic for type 2 diabetes cure is expected to pick pace significantly in the forthcoming years.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org